Alessandro Sannino
Corporate Officer/Principal at University of Salento
Net worth: 2 410 $ as of 31/12/2023
Alessandro Sannino active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Salento | Corporate Officer/Principal | 01/09/2000 | - |
Career history of Alessandro Sannino
Former positions of Alessandro Sannino
| Companies | Position | Start | End |
|---|---|---|---|
| GELESIS HOLDINGS, INC. | Corporate Officer/Principal | 13/01/2022 | 30/10/2023 |
| GELESIS INC | Corporate Officer/Principal | 01/05/2008 | 01/01/2022 |
Academica Life Science SRL
 Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Founder | 26/05/2010 | - |
| President | 01/04/2006 | - |
Training of Alessandro Sannino
| Università degli Studi di Napoli Federico II | Doctorate Degree |
| University of Washington | Doctorate Degree |
Statistics
International
| Italy | 4 |
| United States | 4 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Founder | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Academica Life Science SRL
Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Commercial Services |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Alessandro Sannino
- Experience
